Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Silent Cerebral Infarct Multi-Center Clinical Trial Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Silent Cerebral Infarct Multi-Center Clinical Trial conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Silent Cerebral Infarct Multi-Center Clinical Trial Clinical research trials and Silent Cerebral Infarct Multi-Center Clinical Trial medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Silent Cerebral Infarct Multi-Center Clinical Trial. Silent Cerebral Infarct Multi-Center Clinical Trial Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Silent Cerebral Infarct Multi-Center Clinical Trial clinical trial. Subjects often receive the most expert healthcare possible for their Silent Cerebral Infarct Multi-Center Clinical Trial condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Silent Cerebral Infarct Multi-Center Clinical Trial

Silent Cerebral Infarct Multi-Center Clinical Trial



Silent Cerebral Infarct Multi-Center Clinical Trial

For Condition: Stroke,Sickle Cell Anemia
Status: Not yet recruiting
Sponsor(s): National Institute of Neurological Disorders and Stroke (NINDS) ,
Synopsis: The goal of this study is to determine the effectiveness of blood transfusion therapy for prevention of silent cerebral infarct (stroke) in children with sickle cell anemia.
Details: Silent cerebral infarct (stroke) is the most common cause of severe cognitive impairments and related neurological functions in children with sickle cell anemia. Currently there exists no systemic strategy to identify or treat children with silent strokes. The primary aim of this trial is to determine the effectiveness of blood transfusion therapy for the prevention of silent strokes in children with sickle cell anemia. This trial will also determine if blood transfusion therapy will prevent further cerebral injury and if the measured benefits of the therapy outweigh the risks associated with it. Participants in this multi-center trial will be randomly assigned to one of 2 groups-the blood transfusion group or the observation group. Those in the blood transfusion group will receive at least monthly blood transfusion therapy. All participants will have history and physical examinations every 3 months, and magnetic resonance imaging (MRI) at the beginning of their entry into the study, 12 to 18 months after study entry, and at study exit. Advances in the understanding and treatment of silent strokes will likely lead to a decrease in the burden associated with cerebral injury in children with sickle cell anemia and change the standard care for these children.
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Efficacy Study
Minimum Age/Maximum Age: 6 Years/12 Years
Genders: Both
Protocol Entry Criteria: INCLUSION: - Patient must have sickle cell anemia (hemoglobin SS) or sickle beta thalassemia (hemoglobin SB) as confirmed at the local institution. Participating institutions must submit documentation of the diagnostic hemoglobin analysis to the Statistical and Clinical Coordinating Centers to confirm the diagnosis of sickle cell anemia prior to randomization. - Patient must be 6 through 12 years of age. - Patient must have a cerebral infarct documented by MRI scan as read by the neuroradiology panel. - Informed consent with assent in accordance with the institutional policies (institutional IRB approval) and Federal guidelines (approved by the United States Department of Health and Human Services) must be signed by the patient's legally authorized guardian acknowledging written consent to join the study. When suitable, patients will be requested to give their assent to join the study. EXCLUSION: - Patient with a history of a focal neurologic event lasting more than 24 hours with medical documentation or a history of prior overt stroke. - Patients with a transcranial doppler (TCD) study with a time-averaged mean velocity greater than 200 cm/sec verified by the study radiologist. - Patients with other neurological problems, such as neurofibromatosis, lead poisoning, or tuberous sclerosis. - Patients with HIV infection. - Pregnancy. - Patients who received treatment with anti-sickling drugs or hydroxyurea within 3 months or anticipate receiving anti-sickling drugs or hydroxyurea during the course of the study. - Abnormal kidney function (creatinine > 2x upper limit of normal). - Patients on chronic blood transfusion therapy for other reasons. - Patients judged not likely to be compliant by his/her hematologist and local nurse coordinator based on previous compliance in clinic appointments and following advice. Specifically, families that have missed at least two appointments without notification within 12 months prior to the trial or parents of potential patients that have been reported for medical or education neglect are not eligible for this trial. - Patients unable to receive blood transfusion because of alloimmunization. - Patients with permanent or semi-permanent metallic (braces on teeth) structures attached to their body. Such patients cannot obtain a MRI of the head to assess the presence of silent cerebral infarcts. - Siblings randomized in the trial.
Total Enrollment: 204

Location and Contact Information:

Overall Study Official:
MichaelDeBaun,  Principal Investigator,  Washington University School of Medicine

Washington University School of Medicine
St. Louis,  Missouri, 
United States
Cindy  Terrill 314-286-1169


Additional Information:
Study ID Numbers:  R01NS42804; 
Study Start Date: September 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00072761

Other Sickle Cell Anemia Studies:
1. Brain Processing of Language Meanings

2. Carotid Occlusion Surgery Study

3. Comparison of safety and efficacy of tizanidine hydrochloride capsules versus Zanaflex® (tizanidine hydrochloride tablets) taken while in the fed state (just after a meal) and in the fasted state (before a meal) in patients with moderate to severe spasticity.

4. FNS and Weight Support Treadmill Training for Gait Component Restoration

5. Video-Based Functional Performance and Assessment Following Stroke

Related Studies:

Other Sickle Cell Anemia Clinical Trials
Other Missouri Clinical Trials
Other St. Louis Clinical Trials

Silent Cerebral Infarct Multi-Center Clinical Trial
Modify your Search

  Other Sickle Cell Anemia Clinical Trials
  Other Missouri Clinical Trials
  Other St. Louis Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103